Eton Pharmaceuticals, Inc.
ETON
$30.53
$0.581.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.55M | 1.48M | -1.93M | -2.59M | -1.57M |
| Total Depreciation and Amortization | 1.13M | 1.02M | 1.01M | 1.01M | 1.01M |
| Total Amortization of Deferred Charges | 118.00K | 175.00K | 179.00K | 48.00K | 294.00K |
| Total Other Non-Cash Items | 2.11M | 3.15M | 2.42M | 3.32M | 2.47M |
| Change in Net Operating Assets | 2.49M | -17.37M | 10.34M | 6.18M | -114.00K |
| Cash from Operations | 7.41M | -11.55M | 12.03M | 7.96M | 2.09M |
| Capital Expenditure | -75.00K | -49.00K | -284.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -- | -- | -- | -- |
| Cash from Investing | -15.08M | -49.00K | -284.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.39M | 421.00K | 0.00 | 0.00 | 394.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.39M | 421.00K | 0.00 | 0.00 | 394.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.28M | -11.18M | 11.74M | 7.96M | 2.48M |